Dr Kylie Crompton
Dr Kylie Crompton
Dr Kylie Crompton is a research scientist with a background in biomaterials for regenerative medicine. She completed her PhD in tissue engineering at Monash University in 2007, was employed as Research Scientist at PolyNovo Biomaterials Pty Ltd until 2009 and then took a career break. Dr Crompton started as Research Officer at Murdoch Children's Research Institute in 2012. Her research focuses on cerebral palsy, the most common physical disability of childhood.
Dr Crompton supports clinical trials across the Neurodisability and Rehabilitation research group.
Dr Crompton supports clinical trials across the Neurodisability and Rehabilitation research group.
Dr Kylie Crompton is a research scientist with a background in biomaterials for regenerative medicine. She completed her PhD in tissue engineering at Monash University in 2007, was employed as Research Scientist at PolyNovo Biomaterials Pty Ltd until...
Dr Kylie Crompton is a research scientist with a background in biomaterials for regenerative medicine. She completed her PhD in tissue engineering at Monash University in 2007, was employed as Research Scientist at PolyNovo Biomaterials Pty Ltd until 2009 and then took a career break. Dr Crompton started as Research Officer at Murdoch Children's Research Institute in 2012. Her research focuses on cerebral palsy, the most common physical disability of childhood.
Dr Crompton supports clinical trials across the Neurodisability and Rehabilitation research group.
Dr Crompton supports clinical trials across the Neurodisability and Rehabilitation research group.
Top Publications
- Crompton, K, Novak, I, Fahey, M, Badawi, N, Lee, KJ, Mechinaud-Heloury, F, Edwards, P, Colditz, P, Soosay Raj, T, Hough, J, et al. Safety of sibling cord blood cell infusion for children with cerebral palsy. Cytotherapy 2022 view publication
- Jin, SC, Lewis, SA, Bakhtiari, S, Zeng, X, Sierant, MC, Shetty, S, Nordlie, SM, Elie, A, Corbett, MA, Norton, BY, et al. Author Correction: Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nature Genetics 53(3) : 412 -412 2021 view publication
- Jin, SC, Lewis, SA, Bakhtiari, S, Zeng, X, Sierant, MC, Shetty, S, Nordlie, SM, Elie, A, Corbett, MA, Norton, BY, et al. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nature Genetics 52(10) : 1046 -1056 2020 view publication
- Crompton, K, Novak, I, Fahey, M, Badawi, N, Wallace, E, Lee, K, Mechinaud-Heloury, F, Colditz, PB, Elwood, N, Edwards, P, et al. Single group multisite safety trial of sibling cord blood cell infusion to children with cerebral palsy: study protocol and rationale. BMJ Open 10(3) : e034974 2020 view publication
- Mohandas, N, Bass-Stringer, S, Maksimovic, J, Crompton, K, Loke, YJ, Walstab, J, Reid, SM, Amor, DJ, Reddihough, D, Craig, JM. Epigenome-wide analysis in newborn blood spots from monozygotic twins discordant for cerebral palsy reveals consistent regional differences in DNA methylation. Clinical Epigenetics 10(1) : 25 2018 view publication
Page 1 of 4
Professional activities
Share //
